SCHEMBL20812910

SCHEMBL20812910

c1ccc(-c2ccc(-c3ccc(N(c4ccc(-c5ccccc5)cc4)c4cccc(-c5ccccc5-n5c6ccccc6c6ccccc65)c4)cc3)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
ATM Q13315 1/20 0.38
ALDH1A1 P00352 2/20 0.37
TSPO P30536 1/20 0.33
APP P05067 1/20 0.33
MAPK14 Q16539 1/20 0.32
BRD4 O60885 1/20 0.31
HDAC4 P56524 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ASH1L Q9NR48 3/20 0.30
PDE6D O43924 1/20 0.30
MCL1 Q07820 1/20 0.30
ACMSD Q8TDX5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17722286 1.00 KDM4E (0.38) KDM4EL3MBTL1ATMALDH1A1TSPO
SCHEMBL24902976 0.97 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1TSPO
SCHEMBL20812980 0.97 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1TSPO
SCHEMBL20812997 0.97 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1TSPO
SCHEMBL24902252 0.97 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1TSPO
SCHEMBL24902324 0.97 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1TSPO
SCHEMBL24902953 0.97 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1TSPO
SCHEMBL24090034 0.97 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1TSPO
SCHEMBL24902535 0.97 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1TSPO
SCHEMBL24902329 0.97 KDM4E (0.36) KDM4EL3MBTL1ATMALDH1A1TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3360859-B1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO (JP) 2022-12-14 EP disclosed
US-10464895-B2 Compound, material for organic electroluminescence elements, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-11-05 US disclosed
US-20190077754-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD (JP) 2019-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10464895-B2 Compound, material for organic electroluminescence elements, organic electroluminescence element, and electronic device PIEZO1, RER1, L1CAM KDM4E 2962/4885L3MBTL1 266/4885ATM 2301/4885
US-20190077754-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENTS, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE PIEZO1, RER1, L1CAM KDM4E 2962/4885L3MBTL1 266/4885ATM 2301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.